My Account Log in

4 options

Stem cells and regenerative medicine Volume VII, Diseases and therapy / Philippe Taupin.

EBSCOhost Academic eBook Collection (North America) Available online

View online

EBSCOhost Ebook Medical Collection Available online

View online

Ebook Central Academic Complete Available online

View online

Ebook Central College Complete Available online

View online
Format:
Book
Author/Creator:
Taupin, Philippe.
Series:
Stem Cells and Regenerative Medicine
Stem cells and regenerative medicine, 2159-8754 ; v. 7
Language:
English
Subjects (All):
Stem cells.
Regenerative medicine.
Physical Description:
1 online resource (238 p.)
Edition:
1st ed.
Place of Publication:
New York : Nova Science Publishers, Inc., 2012.
Language Note:
English
Summary:
Stem cells are the building blocks of the body and can develop into any of the cells that make up our bodies. Stem cells carry a lot of hope for the treatment of a broad range of diseases and injuries, spanning from cancers, diabetes, genetic diseases, graft-versus-host disease, eye, heart and liver diseases, inflammatory and autoimmune disorders, to neurological diseases and injuries, particularly neurodegenerative diseases, like Alzheimer's and Parkinson's disease and many others. This book provides an overview and in-depth analysis of recent developments in stem cell research and therapy. It is composed of recently published review articles that went through a peer-review process.
Contents:
Intro
STEM CELLS AND REGENERATIVE MEDICINE VOLUME VII DISEASES AND THERAPY
Contents
Introduction Adult Neurogenesis and Neural Stem Cells: Developmental and Therapeutic Potential
Acknowledgments
Chapter I Enhanced Neurogenesis following Neurological Disease
Abstract
Adult Neurogenesis in Alzheimer's Disease and in Neurodegenerative Diseases of the Brain
Huntington's Disease
Parkinson's Disease
Adult Neurogenesis in Epilepsy
Function of the Newly Generated Neuronal Cells in Neurological Diseases
Therapy
Stimulation of Endogenous Neural Progenitor Cells
Transplantation
Conclusions
References
Chapter II Alzheimer's Disease: Increased Neurogenesis and Possible Disease Mechanisms Related to Neurogenesis
Etiology and Pathology of Alzheimer' s Disease
Amyloid Plaques and Neurofibrillary Tangles
Genetic Factors and Mutations
Aneuploidy
Enhanced Neurogenesis
Possible Mechanisms Related to Adult Neurogenesis
Aneuploidy in AD Patients
Aneuploidy for Chromosome 21 and Amyloid Deposits
Aneuploidy for Chromosome 17 and Neurofibrillary Tangles Formation
Aneuploidy for Chromosomes 1, 14 and 19 and Pathogenesis of AD
Aneuploidy and Adult Neurogenesis
Factors Promoting Aneuploidy in Alzheimer's Disease
Hyperphosphorylation of Tau Protein
Mutation in PSEN1
Modulation of Adult Neurogenesis
Oxidative Stress
Conclusion and Perspectives
Chapter III Neurogenesis, NSCs, Pathogenesis and Therapies for Alzheimer's Disease
Abbreviations
Introduction
Adult Neurogenesis and Neural Stem Cells
Neurogenesis in the Adult Brain of Mammals
Neural Progenitor and Stem Cells In Vitro.
Modulation of Adult Neurogenesis In Vivo
Cellular Therapy
Alzheimer's Disease
A Senile Dementia and Neurodegenerative Disease
Genetic Mutations and Risks Factors in Alzheimer's Disease
Aneuploidy in Region of Neurodegeneration
Adult Neurogenesis and the Pathogenesis of Alzheimer's Disease
Neurogenesis in Alzheimer's Disease
Aneuploid Newly Generated Neuronal Cells in the Adult Brain with Alzheimer's Disease
Novel Drug Targets for Alzheimer's Disease
Newly Generated Neuronal Cells of the Adult Brain
Aneuploid Newly Generated Neuronal Cells of the Adult Brain
Summary and Perspectives
Chapter IV Adult Neurogenesis and Drug Therapy*
Neurogenesis in the Adult Mammalian Brain
Neurogenesis and Neurological Diseases, Disorders and Injuries
Neurogenesis in Neurodegenerative Diseases and Disorders
Neurogenesis and Injuries
Discussion
Stimulation of Neurogenesis
Drug Therapy
Conclusion
Chapter V Neurogenic Factors Are Targets in Depression
Adult Neurogenesis and Depression
Adult Neurogenesis and the Pharmacology of Depression
The Hippocampus and Depression
Limitations of Paradigms and Models to Study Adult Neurogenesis and Depression
Chapter VI Pharmacology of Adult Neurogenesis: Compensatory and Regenerative Processes
Pharmacology of Adult Neurogenesis in Alzheimer's Disease
Alzheimer's Disease and Drug Therapy
Adult Neurogenesis and Alzheimer's Disease Drugs
Pharmacology of Adult Neurogenesis in Depression
Depression and Antidepressants
Adult Neurogenesis and Antidepressants
Discussion.
Drug Therapy: Compensatory Processes
Adult Neurogenesis in Neurological Diseases and Disorders: Regenerative Processes
Adult Neural Stem Cells and Regenerative Medicine
Chapter VII Adult Neurogenesis, Neuroinflammation, and Therapeutic Potential of Adult Neural Stem Cells
Neurogenesis and Neural Stem Cells in the Adult CNS
Adult Neurogenesis in Neurological Diseases and Disorders
Depression
Epilepsy
Therapeutic Potential of Adult Neural Stem Cells
Stimulation of Neural Progenitor or Stem Cells of the Adult CNS
Transplantation of Neural Progenitor and Stem Cells of the Adult CNS
Neuroinflammation and the Therapeutic Potential of Adult NSCs
Neuroin ammation in Neurological Diseases and Injuries
Neuroin ammation in Adult Neurogenesis
Neuroin ammation and Neural Progenitor and Stem Cell Transplantation
Limitations and Pitfalls of BrdU Labelling for Studying Neurogenesis
Conclusions and Perspectives
Chapter VIII A Dual Activity of ROS and Oxidative Stress on Adult Neurogenesis and Alzheimer's Disease*
Alzheimer's Disease Is Caused by Excessive Rate of Genome Damage
Enhanced Neurogenesis in Alzheimer's Disease
Oxidative Stress Contributes to the Pathogenesis of Alzheimer's Disease
A Dual Activity of ROS and Oxidative Stress on Adult Neurogenesis and on the Pathogenesis of Alzheimer's Disease
ROS and Oxidative Stress Control the Cell Cycle and Genomic Stability
Concluding Remarks
Chapter IX Adult Neurogenesis and Neural Stem Cells as a Model for the Discovery and Development of Novel Drugs
Introduction.
Adult Neurogenesis and Drugs to Treat Neurological Diseases and Disorders
Adult Neurogenesis and NSCs Are Targets of Drugs Used for Treating Neurological Diseases and Disorders
Neurogenic Drugs to Reverse or Compensate Deficits and Impairments Associated with the Hippocampus
Expert Opinion
Adult NSCs: A Promising Model to Discover and Develop Neurogenic Drugs
Limitations and Pitfalls of Adult NSCs for Discovering and Developing Neurogenic Drugs
Declaration of Interest
Bibliography
Chapter X Neurogenic Drugs and Compounds*
Recent patents on Compounds and Drugs Modulating Neurogenesis in the Adult Brain Nootropic Agents
The Activity of 15 Compounds and their Derivatives
Apigenin and Related Compounds
Current and Future Developments
Conflict of Interest
Chapter XI Very Small Embryonic-like Stem Cells for Regenerative Medicine*
Background
Methods
Results
Chemistry
Biology and Action
Chapter XII Transplantation of Cord Blood Stem Cells for Treating Hematologic Diseases and Strategies to Improve Engraftment
Executive Summary
HSCs and Cord Blood Stem Cells
Selectins and the Homing of HSCs
P- and E-selectins and Selectin Glycoprotein Ligands
Homing of Hematopoietic Progenitor and Stem Cells of the BM and CB
Transplantation of Cord Blood Stem Cells for the Treatment of Hematologic Diseases
Total Nucleated Cell Count and Age of Patients
Early Infections and Delayed Engraftment
Graft-versus-Host Disease
Strategies to Improve the Outcome of CB Transplantation for the Treatment of Hematologic Diseases.
Direct Delivery of Cord Blood Stem Cells to the Bone Marrow
Transplantation of Double Cord Blood Units
Fucosylation of Selectin Glycoprotein Ligands Ex Vivo
Expansion and Propagation of Cord Blood Stem Cells In Vitro
Future Perspectives
Financial and Competing Interests Disclosure
Chapter XIII Transplantation of Two Populations of Stem Cells to Improve Engraftment*
Transplant
Chapter XIV Ex Vivo Fucosylation of Stem Cells to Improve Engraftment*
Objective
In Vivo and In Vitro Studies
Fucosyltransferases
Chapter XV Thirteen Compounds Promoting Oligodendrocyte Progenitor Cell Differentiation and Remyelination for Treating Multiple Sclerosis
Chemistry and Synthesis
Culture of Oligodendrocyte Progenitor Cells
Cerebellar Organotypic Cultures and Lysolecithin Demyelination
Zebrafish Model
Cuprizone-mediated Demyelination Mouse Model
Other Assays
Drug Screenings
Primary Screening
Secondary Screening
Chapter XVI Antibodies against CD20 (Rituximab) for Treating Multiple Sclerosis
Acknowledgments.
Bibliography.
Notes:
Description based upon print version of record.
Includes bibliographical references and index.
ISBN:
1-62081-121-9
OCLC:
923665378

The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.

Find

Home Release notes

My Account

Shelf Request an item Bookmarks Fines and fees Settings

Guides

Using the Find catalog Using Articles+ Using your account